Corteva (NYSE:CTVA) Stock Moved Down to “Strong Sell” by Zacks Research

Zacks Research cut shares of Corteva (NYSE:CTVA) from a hold rating to a strong sell rating in a research note published on Tuesday morning,Zacks reports.

A number of other research firms have also recently issued reports on CTVA. Weiss Ratings cut shares of Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, August 3rd. Barclays increased their price target on Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a report on Thursday, June 11th. UBS Group raised their price objective on Corteva from $85.00 to $90.00 and gave the company a “neutral” rating in a research note on Wednesday, September 16th. Bank of America boosted their price objective on Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a report on Monday, July 20th. Finally, Morgan Stanley reaffirmed an “overweight” rating and set a $18.00 target price on shares of Corteva in a research report on Friday, October 2nd. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $67.45.

Corteva Trading Up 4.7%

NYSE CTVA opened at $14.56 on Tuesday. Corteva has a one year low of $11.74 and a one year high of $90.97. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. The business has a 50 day simple moving average of $74.30 and a 200 day simple moving average of $79.19. The stock has a market capitalization of $9.72 billion, a P/E ratio of 9.64, a P/E/G ratio of 0.73 and a beta of 0.57.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The company had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. During the same quarter last year, the firm posted $2.20 EPS. The company’s quarterly revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Research analysts expect that Corteva will post 2.77 earnings per share for the current year.

Corteva Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st were issued a dividend of $0.18 per share. The ex-dividend date was Tuesday, September 1st. This represents a $0.72 annualized dividend and a yield of 4.9%. Corteva’s dividend payout ratio is 47.68%.

Institutional Investors Weigh In On Corteva

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Parkside Financial Bank & Trust grew its position in Corteva by 3.2% in the 2nd quarter. Parkside Financial Bank & Trust now owns 3,729 shares of the company’s stock worth $316,000 after purchasing an additional 116 shares during the last quarter. William B. Walkup & Associates Inc. raised its holdings in shares of Corteva by 2.9% during the first quarter. William B. Walkup & Associates Inc. now owns 4,457 shares of the company’s stock valued at $373,000 after buying an additional 126 shares during the last quarter. HB Wealth Management LLC raised its holdings in shares of Corteva by 0.5% during the second quarter. HB Wealth Management LLC now owns 23,822 shares of the company’s stock valued at $2,018,000 after buying an additional 128 shares during the last quarter. Wilkerson Advisory Group LLC boosted its position in shares of Corteva by 6.7% during the first quarter. Wilkerson Advisory Group LLC now owns 2,112 shares of the company’s stock worth $177,000 after buying an additional 133 shares during the period. Finally, AdvisorNet Financial Inc grew its holdings in Corteva by 2.4% in the 1st quarter. AdvisorNet Financial Inc now owns 5,694 shares of the company’s stock worth $477,000 after buying an additional 135 shares in the last quarter. 81.54% of the stock is owned by hedge funds and other institutional investors.

Key Corteva News

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: JPMorgan upgraded Corteva to Overweight from Neutral and set a $19 price target, implying substantial upside from recent trading levels. The firm views the post-spinoff company as undervalued. JPMorgan Upgrades Corteva to Overweight
• Positive Sentiment: KeyBanc also upgraded Corteva to Overweight following the Vylor spinoff. The second bullish rating reinforces the view that the streamlined Corteva may have better growth and valuation prospects. Corteva upgraded at KeyBanc after spinoff of Vylor
• Positive Sentiment: Options activity has surged. Investors purchased 5,408 call options, compared with typical daily volume of 856. While options flow is not a guarantee of future performance, the increase suggests stronger speculative and institutional interest in further gains.
• Positive Sentiment: Recent coverage has highlighted Corteva’s rally after the spinoff and analyst endorsements, including reports that JPMorgan sees as much as 50% upside at current valuations. Corteva Soars on JPMorgan Upgrade
• Neutral Sentiment: Corteva announced that it will release third-quarter 2026 results after the market close on November 11, followed by a webcast on November 12. The announcement provides a future catalyst but contains no new operating results. Corteva Announces Third-Quarter Earnings Date
• Negative Sentiment: One valuation analysis warned that Corteva could be overvalued after its recent advance. That concern may limit additional upside if future earnings do not support the higher valuation. Corteva Valuation Analysis

About Corteva

Corteva, Inc is an agriculture-focused company that develops and supplies seed, crop protection and digital agriculture products. Its offerings are designed to help farmers improve crop productivity, manage pests and diseases, and support more efficient and sustainable farming practices.

The company’s seed portfolio includes corn, soybean, wheat, sunflower, canola, cotton and other crops, marketed through brands such as Pioneer, Brevant seeds and PhytoGen. Corteva also provides herbicides, insecticides, fungicides, biological products and seed treatments under a range of agricultural brands.

Corteva serves farmers, agricultural retailers and other customers in markets around the world.